A clinical study on EECP therapy entitled “Refractory angina frequencies during 7 weeks treatment by enhanced external counterpulsation in coronary artery disease patients with and without diabetes” was recently published in the Annals of Cardiac Anaesthesia (Volume 22, Issue 4, Page 378-282). This retrospective study by Sahebjami, FR Madani, S Komasi, B Heydarpour, et al, from Kermanshah University of Medical Sciences in Kermanshah, Iran. In this retrospective study of 94 CAD patients (30 diabetics vs. 64 nondiabetics) who were referred to the cardiac rehabilitation department of Imam Ali Hospital of Kermanshah, Iran, during January 2006–2014 were assessed. The interventional method was EECP and medical records and frequencies of self-reported chest pain were the research instruments. Frequencies of pain in both diabetic and nondiabetic groups during 7 weeks had linear reduction, but this reduction was significant only among nondiabetic patients (P< 0.0005). For more information go to: http://www.annals.in/article.asp?issn=0971-9784;year=2019;volume=22;issue=3;spage=278;epage=282;aulast=Sahebjami
Recent News
Recently Published Case Study Explores the Possibility of Using EECP Therapy to Treat Long – COVID POTS
Russian Publications on EECP Therapy Now Added to IEECPS Bibliography
Short-term External Counterpulsation Augments Cerebral Blood Flow and Tissue Oxygenation in Chronic Cerebrovascular Occlusive Disease Presented at ESC
EECP Presentation at ACIM in November
New Counterpulsation Center Opens at Xiangtan City Hospital in China
Russian Publications on EECP Therapy Now Added to IEECPS Bibliography
Short-term External Counterpulsation Augments Cerebral Blood Flow and Tissue Oxygenation in Chronic Cerebrovascular Occlusive Disease Presented at ESC
EECP Presentation at ACIM in November
New Counterpulsation Center Opens at Xiangtan City Hospital in China
Join the IEECPS!
The IEECPS gives you the opportunity to make a contribution and be part of a world wide effort to improve the utilization of EECP Therapy to slow down or prevent the progression of cardiovascular disease.